• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性阿尔茨海默病中功能失调的γ-分泌酶

Dysfunctional γ-Secretase in Familial Alzheimer's Disease.

作者信息

Wolfe Michael S

机构信息

Department of Medicinal Chemistry, University of Kansas, Lawrence, KS, 66045, USA.

出版信息

Neurochem Res. 2019 Jan;44(1):5-11. doi: 10.1007/s11064-018-2511-1. Epub 2018 Apr 4.

DOI:10.1007/s11064-018-2511-1
PMID:29619615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6592691/
Abstract

Genetics strongly implicate the amyloid β-peptide (Aβ) in the pathogenesis of Alzheimer's disease. Dominant missense mutation in the presenilins and the amyloid precursor protein (APP) cause early-onset familial Alzheimer's disease (FAD). As presenilin is the catalytic component of the γ-secretase protease complex that produces Aβ from APP, mutation of the enzyme or substrate that produce Aβ leads to FAD. However, the mechanism by which presenilin mutations cause FAD has been controversial, with gain of function and loss of function offered as binary choices. This overview will instead present the case that presenilins are dysfunctional in FAD. γ-Secretase is a multi-functional enzyme that proteolyzes the APP transmembrane domain in a complex and processive manner. Reduction in a specific function-the carboxypeptidase trimming of initially formed long Aβ peptides containing most of the transmembrane domain to shorter secreted forms-is an emerging common feature of FAD-mutant γ-secretase complexes.

摘要

遗传学有力地表明,淀粉样β肽(Aβ)与阿尔茨海默病的发病机制密切相关。早老素和淀粉样前体蛋白(APP)中的显性错义突变会导致早发性家族性阿尔茨海默病(FAD)。由于早老素是γ-分泌酶蛋白酶复合体的催化成分,该复合体从APP产生Aβ,产生Aβ的酶或底物的突变会导致FAD。然而,早老素突变导致FAD的机制一直存在争议,功能获得和功能丧失被视为两种二元选择。相反,本综述将阐述早老素在FAD中功能失调的情况。γ-分泌酶是一种多功能酶,它以复杂且连续的方式对APP跨膜结构域进行蛋白水解。一种特定功能的降低——将最初形成的包含大部分跨膜结构域的长Aβ肽羧肽酶修剪为较短的分泌形式——是FAD突变型γ-分泌酶复合体的一个新出现的共同特征。

相似文献

1
Dysfunctional γ-Secretase in Familial Alzheimer's Disease.家族性阿尔茨海默病中功能失调的γ-分泌酶
Neurochem Res. 2019 Jan;44(1):5-11. doi: 10.1007/s11064-018-2511-1. Epub 2018 Apr 4.
2
Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.γ-分泌酶的持续性和总活性的分离:对阿尔茨海默病致病早老素突变机制的影响。
Biochemistry. 2011 Oct 25;50(42):9023-35. doi: 10.1021/bi2007146. Epub 2011 Sep 30.
3
Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues.淀粉样蛋白前体中的家族性阿尔茨海默病突变通过 γ-分泌酶改变蛋白水解,从而增加≥45 个残基的淀粉样 β 肽。
J Biol Chem. 2021 Jan-Jun;296:100281. doi: 10.1016/j.jbc.2021.100281. Epub 2021 Jan 12.
4
Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease.分析 APP 中的非淀粉样蛋白生成突变支持阿尔茨海默病的功能丧失假说。
Int J Mol Sci. 2023 Jan 20;24(3):2092. doi: 10.3390/ijms24032092.
5
Processive proteolysis by γ-secretase and the mechanism of Alzheimer's disease.γ-分泌酶的连续蛋白水解作用和阿尔茨海默病的发病机制。
Biol Chem. 2012 Sep;393(9):899-905. doi: 10.1515/hsz-2012-0140.
6
Effects of presenilin-1 familial Alzheimer's disease mutations on γ-secretase activation for cleavage of amyloid precursor protein.早老素-1 家族性阿尔茨海默病突变对 γ-分泌酶激活导致淀粉样前体蛋白裂解的影响。
Commun Biol. 2023 Feb 14;6(1):174. doi: 10.1038/s42003-023-04539-1.
7
Designed Helical Peptides as Functional Probes for γ-Secretase.设计螺旋肽作为 γ-分泌酶的功能探针。
Biochemistry. 2019 Nov 5;58(44):4398-4407. doi: 10.1021/acs.biochem.9b00639. Epub 2019 Oct 28.
8
A computer-simulated mechanism of familial Alzheimer's disease: Mutations enhance thermal dynamics and favor looser substrate-binding to γ-secretase.一种家族性阿尔茨海默病的计算机模拟机制:突变增强了热动力学,有利于γ-分泌酶与底物更松弛地结合。
J Struct Biol. 2020 Dec 1;212(3):107648. doi: 10.1016/j.jsb.2020.107648. Epub 2020 Oct 21.
9
Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ.阿尔茨海默病早老素-1 突变显著减少 γ-分泌酶对长淀粉样 β 肽 (Aβ) 的修剪,从而增加 42-40 残基 Aβ。
J Biol Chem. 2014 Nov 7;289(45):31043-52. doi: 10.1074/jbc.M114.581165. Epub 2014 Sep 19.
10
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.基于对致病性突变的分析的 γ-分泌酶对 APP 加工的构象模型。
Int J Mol Sci. 2021 Dec 18;22(24):13600. doi: 10.3390/ijms222413600.

引用本文的文献

1
and as Modifiers of Age of Onset in Autosomal-Dominant Early-Onset Alzheimer's Disease Caused by the A431E Variant.以及作为由A431E变体引起的常染色体显性早发性阿尔茨海默病发病年龄的修饰因子。
Int J Mol Sci. 2025 Aug 16;26(16):7929. doi: 10.3390/ijms26167929.
2
γ-secretase targeting in Alzheimer's disease.针对阿尔茨海默病的γ-分泌酶靶向治疗
J Alzheimers Dis Rep. 2025 Jun 23;9:25424823251349529. doi: 10.1177/25424823251349529. eCollection 2025 Jan-Dec.
3
The pathogenicity of PSEN2 variants is tied to Aβ production and homology to PSEN1.PSEN2 变体的致病性与 Aβ 生成以及与 PSEN1 的同源性相关。
Alzheimers Dement. 2024 Dec;20(12):8867-8877. doi: 10.1002/alz.14339. Epub 2024 Nov 19.
4
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).γ-分泌酶活性、临床特征和常染色体显性阿尔茨海默病的生物标志物:显性遗传性阿尔茨海默病网络观察研究(DIAN-OBS)的横断面和纵向分析。
Lancet Neurol. 2024 Sep;23(9):913-924. doi: 10.1016/S1474-4422(24)00236-9. Epub 2024 Jul 26.
5
Presenilin Deficiency Results in Cellular Cholesterol Accumulation by Impairment of Protein Glycosylation and NPC1 Function.早老素缺乏通过损害蛋白糖基化和 NPC1 功能导致细胞内胆固醇积累。
Int J Mol Sci. 2024 May 16;25(10):5417. doi: 10.3390/ijms25105417.
6
Early molecular events of autosomal-dominant Alzheimer's disease in marmosets with PSEN1 mutations.早发性常染色体显性阿尔茨海默病 PSEN1 突变猴模型中的早期分子事件。
Alzheimers Dement. 2024 May;20(5):3455-3471. doi: 10.1002/alz.13806. Epub 2024 Apr 4.
7
BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.BIN1 推翻阿尔茨海默病统治的探索:对淀粉样蛋白和 Tau 神经病理学的影响。
Neurotox Res. 2023 Dec;41(6):698-707. doi: 10.1007/s12640-023-00670-3. Epub 2023 Oct 17.
8
iTRAQ-Based Proteomic Analysis of APP Transgenic Mouse Urine Exosomes.基于 iTRAQ 的 APP 转基因小鼠尿液外泌体蛋白质组学分析。
Int J Mol Sci. 2022 Dec 30;24(1):672. doi: 10.3390/ijms24010672.
9
Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic.嘌呤能和胆碱能抗炎途径在 COVID-19 大流行背景下对阿尔茨海默病患者氧化应激的作用。
Neuroscience. 2023 Feb 21;512:110-132. doi: 10.1016/j.neuroscience.2022.12.007. Epub 2022 Dec 13.
10
γ-Secretase as a drug target for familial Alzheimer's disease: the road less traveled.γ-分泌酶作为家族性阿尔茨海默病的药物靶点:鲜有人走的道路。
Future Med Chem. 2022 Oct;14(19):1341-1343. doi: 10.4155/fmc-2022-0178. Epub 2022 Aug 30.

本文引用的文献

1
Presenilin-1 mutations and Alzheimer's disease.早老素-1突变与阿尔茨海默病。
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):629-631. doi: 10.1073/pnas.1619574114. Epub 2017 Jan 12.
2
The amyloid hypothesis of Alzheimer's disease at 25 years.阿尔茨海默病淀粉样蛋白假说25年回顾
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.
3
Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?γ-分泌酶调节剂:即将问世的新型阿尔茨海默病药物?
J Med Chem. 2016 Aug 25;59(16):7389-409. doi: 10.1021/acs.jmedchem.5b01960. Epub 2016 Apr 5.
4
Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ.阿尔茨海默病早老素-1 突变显著减少 γ-分泌酶对长淀粉样 β 肽 (Aβ) 的修剪,从而增加 42-40 残基 Aβ。
J Biol Chem. 2014 Nov 7;289(45):31043-52. doi: 10.1074/jbc.M114.581165. Epub 2014 Sep 19.
5
A phase 3 trial of semagacestat for treatment of Alzheimer's disease.一项用于治疗阿尔茨海默病的司美吉林的 3 期临床试验。
N Engl J Med. 2013 Jul 25;369(4):341-50. doi: 10.1056/NEJMoa1210951.
6
γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43.γ-分泌酶调节剂和早老素 1 突变体对早老素/γ-分泌酶功能的作用不同,从而切割 Aβ42 和 Aβ43。
Cell Rep. 2013 Jan 31;3(1):42-51. doi: 10.1016/j.celrep.2012.11.028. Epub 2013 Jan 3.
7
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.γ-分泌酶抑制剂阿伐加司他在轻度至中度阿尔茨海默病2期研究中的安全性和耐受性
Arch Neurol. 2012 Nov;69(11):1430-40. doi: 10.1001/archneurol.2012.2194.
8
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.APP 中的一个突变可预防阿尔茨海默病和与年龄相关的认知能力下降。
Nature. 2012 Aug 2;488(7409):96-9. doi: 10.1038/nature11283.
9
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.β淀粉样蛋白的神经毒性:突触和网络功能障碍。
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338. doi: 10.1101/cshperspect.a006338.
10
Advances in understanding the molecular basis of frontotemporal dementia.理解额颞叶痴呆分子基础的进展。
Nat Rev Neurol. 2012 Aug;8(8):423-34. doi: 10.1038/nrneurol.2012.117. Epub 2012 Jun 26.